查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球微電子醫療植入物市場-2023-2030
市場調查報告書
商品編碼
1374799

全球微電子醫療植入物市場-2023-2030

Global Microelectronic Medical Implants Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

個人化醫療的發展正在推動對更複雜的醫療設備的需求，包括微電子醫療植入物。遠端患者監測的不斷成長趨勢正在推動對具有無線通訊功能的微電子醫療植入物的需求。

隨著微電子技術的不斷發展，它在醫療領域的應用越來越多。植入式醫療設備不斷擴展到新型療法，提供了越來越多的藥物替代品。心律管理產品是最常見的，應用於心律調節、去顫和心臟再同步。新應用包括帕金森氏症治療、疼痛管理、胃酸逆流監測器和暈厥監測器。

此外，微電子醫療植入物市場受到多種因素的推動，例如主要參與者推出新設備、醫療植入物的技術進步以及新興經濟體醫療保健支出的增加為微電子醫療植入物製造商提供了巨大的成長機會。

動力學

心血管疾病盛行率上升

冠狀動脈疾病、心律不整和心臟衰竭等心血管疾病通常需要心律調節器、除顫器和心臟監視器等植入式裝置。這些疾病的日益普及直接增加了對心血管植入物的需求。

例如，根據美國疾病管制與預防中心更新的 2023 年情況說明書，心臟病是美國男性、女性以及大多數種族和民族群體個人的主要原因。在美國，每 33 秒就有一人死於心血管疾病。

2021 年，美國約有 695,000 人死於心臟病，佔死亡人數的五分之一。 2018年至2019年，美國在心臟病方面的支出約為2.399億美元。這涵蓋了醫療保健服務、藥物的費用以及因死亡而造成的生產力損失。

科技進步的崛起

治療性神經植入物產生電刺激，使神經元恢復正常狀態，類似大腦節律器。這些植入物使用 CMOS 技術整合到微型矽晶片中，從而減小了設備的物理尺寸和功耗。

植入物成本高

利用微電子技術開發和測試植入式醫療設備可能非常昂貴，限制了某些患者和醫療保健系統對這些設備的負擔能力和可近性。

人工耳蝸手術是一種將小型複雜電子設備放置在耳後皮膚下的醫療手術。這種電子設備[人工耳蝸]有助於刺激聽覺神經，使患者能聽到聲音。印度人工耳蝸的費用從 65,870 印度盧比到 430,000 印度盧比不等，最高可達 873,600 印度盧比。平均成本也較高。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按設備類型分類
  • 按應用程式片段
  • 技術片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 心房顫動盛行率上升
      • 科技進步的崛起
    • 限制
      • 繁瑣且過時的動態心電圖分析
    • 機會
      • 新興市場產品發布數量增加
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按裝置類型

  • 心律調節器和除顫器
  • 神經刺激器
  • 植入式藥泵
  • 脊椎融合刺激器
  • 人工耳蝸
  • 眼部植入物
  • 其他

第 8 章：按應用

  • 心臟病學
  • 神經病學
  • 眼科
  • 骨科
  • 其他

第 9 章：按技術

  • 射頻技術
  • 感應器
  • 其他

第 10 章：最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Biotronik
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Boston Scientific Corporation
  • Abbott Laboratories
  • ZOLL Medical Corporation
  • Schiller
  • Medtronic
  • Lepu Medical
  • ZimVie
  • Stryker
  • Avantor, Inc

第 14 章：附錄

簡介目錄
Product Code: MD7216

Overview

The development of personalized medicine is driving the demand for more sophisticated medical devices, including microelectronic medical implants. The growing trend towards remote patient monitoring is driving the demand for microelectronic medical implants with wireless communication capabilities.

As microelectronic technology continues to evolve, it is finding increased applications in the medical sector. Implantable medical devices are continuing to branch out to new types of therapies, posing a continuously growing number of alternatives to medication. Cardiac rhythm management products are the most common, with applications in pacing, defibrillation, and heart resynchronization. New applications include Parkinson's treatment, pain management, acid reflux monitors and syncope monitors.

Furthermore, the microelectronic medical implants market is driven by various factors like, new device launches by key players, technological advancements in medical implants, and increasing healthcare spending in emerging economies presents significant growth opportunities for microelectronic medical implant manufacturers.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Cardiovascular diseases, such as coronary artery disease, arrhythmias, and heart failure, often require implantable devices like pacemakers, defibrillators, and cardiac monitors. The growing prevalence of these conditions directly increases the demand for cardiovascular implants.

For instance, according to the Centers for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 Million on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Therapeutic neural implants produce electrical stimulation to restore neurons to normal conditions, similar to a pacemaker for the brain. These implants are integrated into miniature silicon chips using CMOS technology, reducing the device's physical dimensions and power consumption.

High Cost of Implants

Developing and testing implantable medical devices with microelectronics technology can be expensive, limiting the affordability and accessibility of these devices for some patients and healthcare systems.

Cochlear Implant surgery is a medical procedure in which a small, complex electronic device is placed under the skin behind the ear. This electronic device [Cochlear implant] helps stimulate the auditory nerves and allows the patient to hear. The cost of a Cochlear Implant in India ranges from INR 65,870 to INR 4,30,000, with the maximum cost reaching INR 8,73,600. The average cost is also higher.

Segment Analysis

The global microelectronic medical implants market is segmented based on device type, application, technology, end-user and region.

The Pacemakers & Defibrillators Segment From the Device Type Segment Accounted For Approximately 41.7% of Microelectronic Medical Implants Share

The pacemakers & defibrillators segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. The computer circuits perform the functions of monitoring the patient's underlying heart rhythm and delivering an electrical signal to cause the heart to beat at the desired rate. Microelectronics plays a crucial role in pacemakers, a small, battery-powered device that controls the heart's rhythm. It requires precision manufacturing for proper function and has made pacemakers smaller, durable, and longer-lasting, making them more accessible and affordable.

For instance, in February 2023 Medtronic announced clinical data demonstrating significant improvements in Afib detection using the Reveal Linq. The study compared the Reveal Linq insertable cardiac monitor (ICM) to patients randomized to standard of care. Those patients did not receive continuous long-term monitoring.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors such as a rise in the number of FDA approvals for different products in the U.S., an increase in the prevalence of cardiac diseases, and the presence of favourable government policies in the region.

For instance, in August 2023 BIOTRONIK, a leader in implantable medical device technology, stated its first US implantation of the new Amvia Edge pacemaker.

Competitive Landscape

The major global players in the market include: Biotronik, Boston Scientific Corporation, Abbott Laboratories, ZOLL Medical Corporation, Schiller, Medtronic, Lepu Medical, ZimVie, Stryker, Avantor, Inc. and among others

Key Developments

  • In May 2023 Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.
  • In August 2021, Abbott Laboratories received FDA approval for its Infinity DBS system, a deep brain stimulation device used to treat Parkinson's disease and essential tremors. The device features advanced stimulation technology that allows for personalized therapy and real-time patient feedback.
  • In September 2021, LivaNova announced the launch of its next-generation Vagus Nerve Stimulation (VNS) therapy system for the treatment of epilepsy. The system features advanced simulation technology and offers patients a personalized approach to therapy.

COVID-19 Impact Analysis

The pandemic has resulted in a surge in demand for medical devices such as personal protective equipment, ventilators, and general hospital supplies. On the other hand, the postponement and cancellation of non-essential and elective procedures have impacted financially the manufacturers focusing on devices used in such procedures. The pandemic has also affected the supply chains of medical devices, including microelectronics, which may have caused initial shortages of deliveries.

Why Purchase the Report?

  • To visualize the global microelectronic medical implants market segmentation based on device type, application, technology, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global microelectronic medical implants market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global microelectronic medical implants market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Atrial Fibrillation
      • 4.1.1.2. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Tedious And Outdated Holter ECG Analysis
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in the Product Launches in Emerging Markets
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Pacemakers & Defibrillators*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Neurostimulators
  • 7.4. Implantable Drug Pumps
  • 7.5. Spinal Fusion Stimulators
  • 7.6. Cochlear Implants
  • 7.7. Ocular Implants
  • 7.8. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Neurology
  • 8.4. Ophthalmology
  • 8.5. Orthopedics
  • 8.6. Others

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. RF Technology*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Sensors
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Biotronik *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Boston Scientific Corporation
  • 13.3. Abbott Laboratories
  • 13.4. ZOLL Medical Corporation
  • 13.5. Schiller
  • 13.6. Medtronic
  • 13.7. Lepu Medical
  • 13.8. ZimVie
  • 13.9. Stryker
  • 13.10. Avantor, Inc

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us